Is Comprehensive Genomic Profiling right for your lab?
Download the webinar replay: Comprehensive Genomic Profiling: What’s the Business Case? Hear the experience of an existing OncoDEEP® Kit customer
Wednesday, December 11, 2024
4:00 PM CET
By Dr. Marcel Trautmann (Head of Molecular Diagnostics – Division of Translational Pathology – Universitätsklinikum Münster)
In today’s evolving landscape, labs face an array of options for genomic testing, but choosing the most effective CGP panel can be challenging. As small “hot spot” panels fall short of capturing the complexity needed for advanced cancer care, lab leaders must evaluate the business case for transitioning to a comprehensive CGP solution.
This webinar will equip you with the tools and insights needed to make an informed decision. You’ll leave with a checklist of critical questions to support your CGP panel selection and ensure alignment with your lab’s clinical and business objectives.
!Please note that places are limited!
Thank you for your interest in our last webinar, “Comprehensive Genomic Profiling: What’s the Business Case? Hear the experience of an existing OncoDEEP® Kit customer”, held on December 11, 2024, with Dr. Marcel Trautmann, Head of Molecular Diagnostics at Universitätsklinikum Münster.
Today, selecting the right genomic profiling panel is more crucial than ever. This webinar explored:
- The Business Case for CGP: Key metrics and decision-making factors to transition from traditional panels.
- Cost-Effective CGP Solutions: Practical strategies to optimize costs with tools like the OncoDEEP® Kit.
- Workflow Optimization: How to integrate CGP into routine operations while improving patient outcomes through biomarkers like MSI, TMB, and HRD.
Whether you’re a laboratory manager, clinical pathologist, or involved in genomic technology implementation, this webinar offers tools and insights to guide your decisions.
Replay Webinar Cromprehensive Genomic Profiling - What's the Business Case?
Who should attend?
- This session is ideal for laboratory managers, clinical pathologists, and anyone responsible for evaluating or implementing genomic profiling technologies in clinical settings.
What you'll learn
- Building a strong Business Case for CGP: Understand the essential metrics and decision factors that justify a shift from traditional panels to CGP.
- Cost-effective CGP solutions: Explore practical strategies to optimize costs, including higher sample throughput and reduced hands-on time with the OncoDEEP® Kit.
- Workflow optimization and enhanced patient outcomes: Gain practical guidance on integrating CGP into your lab’s routine while supporting better outcomes through comprehensive biomarker analysis (MSI, TMB, HRD, etc.).
Speaker
Chair of the Webinar
Marcel Trautmann
Assistant Professor & Head Molecular Diagnostics and Research — Division of Translational Pathology, Gerhard-Domagk-Institute of Pathology, University Hospital Münster
Amanda Bassett
Head of Partnerships (UK) at OncoDNA
